|
|
|
| home > white papers > Bringing more control to temperature-sensitive logistics - UPS Supply Chain Solutions |
|
|
 WHITE PAPERS |
|
|
UPS Supply Chain Solutions
|
|
Bringing more control to temperature-sensitive logistics
|
|
By 2016, world sales of cold-chain drugs and biologics such as vaccines
and blood plasma products will near $240 billion1. The increase has led
to a surge in discussion about how to protect these products throughout
the transportation logistics cycle. Industry experts are recommending
that the term “cold chain” be eliminated from rules, guidance and
best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room
temperature (CRT). This white paper focuses on the initial steps
required to establish a temperature-sensitive supply chain.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Turkish Cargo keeps growing in the first quarter of 2019
Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >> |
|
 |
White Papers |
 |
|
Device Develop for Combo Products
Phillips-Medisize
Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Washington
27-29 September 2020, Walter E Washington Convention Center, Washington, US
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
|
